Literature DB >> 24199026

Non-dietary forms of treatment for adult celiac disease.

Hugh James Freeman1.   

Abstract

At present, treatment for celiac disease includes a strict gluten-free diet. Compliance, however, is difficult and gluten-free food products are costly, and, sometimes very inconvenient. A number of potential alternative measures have been proposed to either replace or supplement gluten-free diet therapy. In the past, non-dietary forms of treatment were used (e.g., corticosteroids) by some clinicians, often to supplement a gluten-free diet in patients that appeared to be poorly responsive to a gluten-free diet. Some of new and novel non-dietary measures have already advanced to a clinical trial phase. There are still some difficulties even if initial studies suggest a particularly exciting and novel form of non-dietary treatment. In particular, precise monitoring of the response to these agents will become critical. Symptom or laboratory improvement may be important, but it will be critical to ensure that ongoing inflammatory change and mucosal injury are not present. Therapeutic trials will be made more difficult because there is already an effective treatment regimen.

Entities:  

Keywords:  Adult celiac disease; Gluten-free diet; Immunotherapy; Non-dietary treatment of celiac disease; Protease; Tight junction inhibition; Vaccination

Year:  2013        PMID: 24199026      PMCID: PMC3817285          DOI: 10.4292/wjgpt.v4.i4.108

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  39 in total

Review 1.  Small intestinal mucosal biopsy for investigation of diarrhea and malabsorption in adults.

Authors:  H J Freeman
Journal:  Gastrointest Endosc Clin N Am       Date:  2000-10

2.  The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.

Authors:  Maud Pinier; Gregor Fuhrmann; Heather J Galipeau; Nathalie Rivard; Joseph A Murray; Chella S David; Hana Drasarova; Ludmila Tuckova; Jean-Christophe Leroux; Elena F Verdu
Journal:  Gastroenterology       Date:  2011-11-10       Impact factor: 22.682

3.  Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.

Authors:  Sandro Drago; Ramzi El Asmar; Mariarosaria Di Pierro; Maria Grazia Clemente; Amit Tripathi; Anna Sapone; Manjusha Thakar; Giuseppe Iacono; Antonio Carroccio; Cinzia D'Agate; Tarcisio Not; Lucia Zampini; Carlo Catassi; Alessio Fasano
Journal:  Scand J Gastroenterol       Date:  2006-04       Impact factor: 2.423

4.  Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.

Authors:  S M Stenman; K Lindfors; J I Venäläinen; A Hautala; P T Männistö; J A Garcia-Horsman; A Kaukovirta-Norja; S Auriola; T Mauriala; M Mäki; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2010-06-15       Impact factor: 4.330

Review 5.  Prevention measures and exploratory pharmacological treatments of celiac disease.

Authors:  Maud Pinier; Gregor Fuhrmann; Elena F Verdu; Elena Verdu; Jean-Christophe Leroux
Journal:  Am J Gastroenterol       Date:  2010-09-28       Impact factor: 10.864

6.  Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.

Authors:  C P Kelly; P H R Green; J A Murray; A Dimarino; A Colatrella; D A Leffler; T Alexander; R Arsenescu; F Leon; J G Jiang; L A Arterburn; B M Paterson; R N Fedorak
Journal:  Aliment Pharmacol Ther       Date:  2012-11-19       Impact factor: 8.171

7.  Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.

Authors:  Dariusz Stepniak; Liesbeth Spaenij-Dekking; Cristina Mitea; Martine Moester; Arnoud de Ru; Renee Baak-Pablo; Peter van Veelen; Luppo Edens; Frits Koning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-11       Impact factor: 4.052

8.  Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease.

Authors:  J Arturo Garcia-Horsman; Jarkko I Venäläinen; Olli Lohi; I Seppo Auriola; Ilma R Korponay-Szabo; Katri Kaukinen; Markku Mäki; Pekka T Männistö
Journal:  Scand J Gastroenterol       Date:  2007-05       Impact factor: 2.423

9.  Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.

Authors:  Justin L Piper; Gary M Gray; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2004-05-13       Impact factor: 4.030

10.  A non-human primate model for gluten sensitivity.

Authors:  Michael T Bethune; Juan T Borda; Erin Ribka; Michael-Xun Liu; Kathrine Phillippi-Falkenstein; Ronald J Jandacek; Gaby G M Doxiadis; Gary M Gray; Chaitan Khosla; Karol Sestak
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  7 in total

Review 1.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 2.  Coeliac disease and gluten-related disorders in childhood.

Authors:  Sabine L Vriezinga; Joachim J Schweizer; Frits Koning; M Luisa Mearin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-23       Impact factor: 46.802

Review 3.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

Review 4.  Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms.

Authors:  Hugh J Freeman
Journal:  Gut Liver       Date:  2015-01       Impact factor: 4.519

5.  Role of Immune and Autoimmune Dysfunction in Schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Handb Behav Neurosci       Date:  2015-11-10

6.  Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.

Authors:  María de Lourdes Moreno; Ángel Cebolla; Alba Muñoz-Suano; Carolina Carrillo-Carrion; Isabel Comino; Ángeles Pizarro; Francisco León; Alfonso Rodríguez-Herrera; Carolina Sousa
Journal:  Gut       Date:  2015-11-25       Impact factor: 23.059

7.  Evaluation of Non-dietary Alternatives for Treatment of Adults With Celiac Disease.

Authors:  Hugh James Freeman
Journal:  Front Nutr       Date:  2020-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.